Application of classic formulae in treatment of hypertension

Zhongguo Zhongyao Zazhi

Volumn 38, Issue 11, 2013, Pages 1836-1839

  Xiong, Xing Jiang ^a   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Classic formula; Hypertension; Traditional Chinese medicine therapy

Indexed keywords

ARTICLE; BLOOD PRESSURE; BODY CONSTITUTION; HYPERTENSION; PATHOGENESIS; PREHYPERTENSION; SYSTEMATIC REVIEW;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUGS, CHINESE HERBAL; HUMANS; HYPERTENSION;

EID: 84880145079     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20131138     Document Type: Article

References (35)

1. Sliwa K, Stewart S, Gersh B J. Hypertension: a global perspective [J]. Circulation, 2011, 123: 2892.
2. Schlaich M P, Sobotka P A, Krum H, et al. Renal sympathetic-nerve ablation for uncontrolled hypertension [J]. N Engl J Med, 2009, 361 (9): 932.
3. Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) [J]. J Hypertens, 2007, 25: 1105.
4. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document [J]. J Hypertens, 2009, 27: 2121.
5. Feldman H A, Johannes C B, Derby C A, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study [J]. Prev Med, 2000, 30(4): 328.
6. Keene L C, Davies P H. Drug-related erectile dysfunction [J]. Adverse Drug React Toxicol Rev, 1999, 18(1): 5.
7. Buranakitjaroen P, Phoojaroenchanachai M, Saravich S. Prevalence of erectile dysfunction among treated hypertensive males [J]. J Med Assoc Thai, 2006, 89(S5): S28.
8. Baumhakel M, Schlimmer N, Bohm M. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome [J]. Int J Impot Res, 2008, 20(5): 493.
9. Wang J, Wang P Q, Xiong X J. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine [J]. Int Med, 2012, doi: 10.4172/2165-8048.1000113.
10. Chen K J, Hui K K, Lee M S, et al. The potential benefit of complementary/alternative medicine in cardiovascular diseases [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/125029.
11. Xiong X J, Chu F Y, Li H X, et al. Clinical application of the TCM classic formulae for treating chronic bronchitis [J]. J Tradit Chin Med, 2011, 31 (1): 69.
12. 1999, 27(12): 17.
13. 2011, 52(23): 1985.
14. 2013, 38(8): 1251.
15. 2012, 27(11): 2862.
16. Wang J, Yao K W, Yang X C, et al. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/714805.
17. Xiong X J, Yang X C, Liu W, et al. Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/271462.
18. Xiong X J, Yang X C, Feng B, et al. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials [J]. Evid-Based Compl Alt Med, 2013, doi: 10.1155/2013/982380.
19. Wang J, Yang X C, Feng B, et al. Is Yangxue Qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? [J]. Evid-Based Compl Alt Med, 2013, doi: 10.1155/2013/540613.
20. Wang J, Xiong X J. Current situation and perspectives of clinical study in integrative medicine in China [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/268542.
21. 2003, 23(10): 724.
22. Hajjar I, Kotchen T A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States (1988-2000) [J]. J Amer Med Assoc, 2003, 290: 199.
23. Manios E, Tsivgoulis G, Koroboki E, et al. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass [J]. Stroke, 2009, 40(4): 1515.
24. Drukteinis J S, Roman M J, Fabsitz R R, et al. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the strong heart study [J]. Circulation, 2007, 115(2): 221.
25. Toprak A, Wang H, Chen W, et al. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa heart study[J]. J Hypentens, 2009, 27(2): 243.
26. Lloyd-Jones D M, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association's strategic impact goal through 2020 and beyond [J]. Circulation, 2010, 121: 586.
27. Wang J, Xiong X J. Control strategy on hypertension in Chinese medicine [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/284847.
28. Xiong X J, Yang X C, Liu Y M, et al. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science[J]. Hypertension Res, 2013, doi: 10.1038/hr.2013.18.
29. 2010, 8(1): 20.
30. 2010, 35(4): 536.
31. 2010, 51(3): 200.
32. 2008, 3(1): 4.
33. 2010, 35(10): 1349.
34. 2009, 36(2): 197.
35. Wang J, Xiong X J. Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews [J]. Evid-Based Compl Alt Med, 2012, doi: 10.1155/2012/697237.